Skip to content

13F-HR filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-13, with 65 holding rows worth $395,050,000.

Accession
0001697013-20-000004
Filed
2020-05-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2020

A holdings report, 65 entries on the cover page, a total value of $395,050,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $395,050,000 with VALUE read as thousands by filing date, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZOGENIX INC.98978L204Common Stock2,013,467$49,793,000thousands by filing date
Danaher Corporation235851102COM233,957$32,419,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR275,494$31,023,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock2,461,137$24,218,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM899,474$24,097,000thousands by filing date
CHEMOCENTRYX INC16383L106COM580,011$23,305,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR510,571$19,855,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM414,081$17,048,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR352,551$15,745,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock7,542,372$15,085,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW3,504,062$14,016,000thousands by filing date
SPDR S&P 500 ETF TR78462F953PUT600$13,653,000thousands by filing date
ENSIGN GROUP INC29358P101COM357,028$13,445,000thousands by filing date
HCA Healthcare Inc40412C101COM101,000$9,075,000thousands by filing date
MODEL N INC607525102COM374,284$8,313,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR189,578$8,288,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM305,485$6,785,000thousands by filing date
DEXCOM INC COM252131107Stock19,537$5,261,000thousands by filing date
TARO PHARMACEUTICAL INDS LTDM8737E108SHS76,459$4,679,000thousands by filing date
KADMON HLDGS INC48283N106COM975,350$4,087,000thousands by filing date
PENNANT GROUP INC70805E109COM282,181$3,996,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM146,550$3,986,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW301,073$3,914,000thousands by filing date
ACCELERON PHARMA INC00434H108COM42,305$3,802,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM106,385$3,620,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM90,047$2,696,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM524,257$2,160,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW181,700$2,142,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK580,350$1,938,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM109,212$1,632,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS172,193$1,595,000thousands by filing date
AGILE THERAPEUTICS INC00847L100COM711,756$1,324,000thousands by filing date
MYOKARDIA INC62857M105COM27,752$1,301,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK78,029$1,277,000thousands by filing date
AUTOLUS THERAPEUTICS PLC SPON05280R100COM210,013$1,258,000thousands by filing date
IMMUNOVANT INC45258J102COM76,866$1,196,000thousands by filing date
LIQUIDIA CORPORATION COM NEW53635D202Stock244,637$1,152,000thousands by filing date
HESKA CORP42805E306COM20,771$1,149,000thousands by filing date
OTONOMY INC68906L105COM561,737$1,107,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM59,774$1,098,000thousands by filing date
TELIGENT INC NEW87960W104COM3,862,903$1,082,000thousands by filing date
SCPHARMACEUTICALS INC810648105COM132,419$980,000thousands by filing date
CYCLERION THERAPEUTICS INC23255M105COM337,145$893,000thousands by filing date
AFFIMED N VN01045108COM560,800$886,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock71,591$812,000thousands by filing date
Inflarx NvN44821101COM195,488$747,000thousands by filing date
ARTARA THERAPEUTICS INC04300J107COM32,478$747,000thousands by filing date
SESEN BIO INC817763105COM1,300,000$729,000thousands by filing date
AQUESTIVE THERAPEUTICS INC COM03843E104Stock300,000$657,000thousands by filing date
IGM BIOSCIENCES INC449585108COM9,770$549,000thousands by filing date
AMARIN CORPORATION PLC -ADR023111956ADR1,500$537,000thousands by filing date
MACROGENICS INC556099109COM91,998$535,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK58,251$492,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM69,708$474,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM122,702$465,000thousands by filing date
EHEALTH INC28238P109COM3,153$444,000thousands by filing date
ALIGN TECHNOLOGY INC016255951COM100$423,000thousands by filing date
PFENEX INC717071104COM46,293$408,000thousands by filing date
AMARIN CORPORATION PLC -ADR023111906ADR10,236$374,000thousands by filing date
AIR LEASE CORP00912X952PUT200$121,000thousands by filing date
ZOGENIX INC98978L904CALL55$55,000thousands by filing date
ILLUMINA INC452327109COM170$46,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock500$36,000thousands by filing date
OPTINOSE INC68404V100COM5,006$22,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122140RIGHT 12/30/20306,000$3,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-20-000004this filing2020-05-13acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000015 base2023-11-08acceptance time not in the bulk data set